Low-Density Lipoproteins, High-Density Lipoproteins (HDL), and HDL-Associated Proteins Differentially Modulate Chronic Myelogenous Leukemia Cell Viability

Low-Density Lipoproteins, High-Density Lipoproteins (HDL), and HDL-Associated Proteins Differentially Modulate Chronic Myelogenous Leukemia Cell Viability

cell metabolism of lipid, lipoprotein interaction, and liver X receptor (LXR) activation is involved in the pathophysiology and treatment of cancer, although the findings vary in models of cancer and lipoprotein profiles. In this study, we investigated the effects of Human -derived low-density lipoprotein (LDL), high-density lipoprotein (HDL) cholesterol, and HDL-associated protein apolipoprotein A1 (apoA1)

Low-Density Lipoproteins, High-Density Lipoproteins (HDL), and HDL-Associated Proteins Differentially Modulate Chronic Myelogenous Leukemia Cell Viability Read More »